MetaADEDB 2.0 @ LMMD
Therapeutic product effect delayed
(UMLS:C4761092)
UMLS ID:
C4761092
MeSH ID:
N/A
Synonym(s)
1.
Therapeutic product effect delayed
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1tasimelteonFAERS: 9US FAERS
2tofacitinibFAERS: 6
Canada Vigilance: 28
Canada Vigilance
US FAERS
3PregabalinFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
4IbuprofenFAERS: 4
Canada Vigilance: 5
Canada Vigilance
US FAERS
5NaproxenFAERS: 4US FAERS
6AcetaminophenFAERS: 3US FAERS
7TadenanFAERS: 3US FAERS
8VareniclineFAERS: 3US FAERS
91-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chlorideFAERS: 2US FAERS
10AN2728FAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Ethylene GlycolFAERS: 2US FAERS
12MethylphenidateFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
13NaltrexoneFAERS: 2US FAERS
14RanitidineFAERS: 2US FAERS
15SugammadexFAERS: 2US FAERS
164-[(1R)-2-[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanolFAERS: 1US FAERS
17AlprazolamFAERS: 1US FAERS
18CetirizineFAERS: 1US FAERS
19ClobetasolFAERS: 1US FAERS
20DronabinolFAERS: 1US FAERS
21FluticasoneFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
22IvabradineFAERS: 1US FAERS
23Lisdexamfetamine DimesylateFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
24MethotrexateFAERS: 1US FAERS
25NortriptylineFAERS: 1US FAERS
26OxcarbazepineFAERS: 1US FAERS
27PantoprazoleFAERS: 1US FAERS
28Sildenafil CitrateFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
29Triamcinolone AcetonideFAERS: 1US FAERS
30benzonatateFAERS: 1US FAERS
31carbidopa, levodopa drug combinationFAERS: 1US FAERS
32dofetilideFAERS: 1US FAERS
33eletriptanFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
34fesoterodineFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
35fexofenadineFAERS: 1US FAERS
36fexofenadineFAERS: 1US FAERS
37insulin aspart, insulin aspart protamine drug combination 30:70FAERS: 1US FAERS
38levocetirizineFAERS: 1US FAERS
39lifitegrastFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
40nepafenacFAERS: 1US FAERS
414-AminopyridineCanada Vigilance: 1Canada Vigilance
42BupivacaineCanada Vigilance: 3Canada Vigilance
43BupivacaineCanada Vigilance: 1Canada Vigilance
44CelecoxibCanada Vigilance: 1Canada Vigilance
45DeferasiroxCanada Vigilance: 1Canada Vigilance
46DextroamphetamineCanada Vigilance: 1Canada Vigilance
47EpinephrineCanada Vigilance: 8Canada Vigilance
48Estrogens, Conjugated (USP)Canada Vigilance: 1Canada Vigilance
49GabapentinCanada Vigilance: 1Canada Vigilance
50GuaifenesinCanada Vigilance: 1Canada Vigilance
51HydrocortisoneCanada Vigilance: 2Canada Vigilance
52LatanoprostCanada Vigilance: 1Canada Vigilance
53LorazepamCanada Vigilance: 5Canada Vigilance
54OctreotideCanada Vigilance: 1Canada Vigilance
55PramipexoleCanada Vigilance: 1Canada Vigilance
56RocuroniumCanada Vigilance: 1Canada Vigilance
57Ruxolitinib phosphateCanada Vigilance: 1Canada Vigilance
58Sildenafil CitrateCanada Vigilance: 1Canada Vigilance
59TadalafilCanada Vigilance: 1Canada Vigilance
60TriiodothyronineCanada Vigilance: 2Canada Vigilance
61magnesium citrateCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.